Jubilant Pharmova Limited has received a Show Cause Notice from the Assistant Commissioner of Commercial Taxes (Enforcement)-4, Mysore, proposing a demand of ₹87.31 crore. This includes GST, interest, and penalty for the financial year 2022-2023, citing alleged ineligible ITC and excess ITC availed. The company is preparing a detailed reply and believes it has a strong case, expecting no financial or operational impact from this notice.
Tax Demand Issued by Mysore Authorities
Jubilant Pharmova Limited announced on September 1, 2026, that it has received a Show Cause Notice from the Assistant Commissioner of Commercial Taxes (Enforcement)-4, Mysore. The notice, issued on August 31, 2026, proposes a demand for Goods and Services Tax (GST), interest, and penalty totaling ₹87.31 crore for the financial year 2022-2023.
Details of the Demand
The proposed demand is based on several alleged issues, including ineligible Input Tax Credit (ITC), excess ITC availed, and differential tax liability identified through E-waybill records. The breakdown of the demand includes ₹33.58 crore for GST (Tax), ₹20.15 crore for Interest, and ₹33.58 crore for Penalty.
Company’s Response and Expected Impact
Jubilant Pharmova Limited stated that the Show Cause Notice is factually and legally incorrect. The company is in the process of preparing a detailed reply, supported by documentary evidence, to be filed before the Assistant Commissioner. The company expressed confidence in its position, indicating that it expects no financial or operational impact from this notice.
The information regarding this event is enclosed as Annexure-A, and the company will also post this announcement on its website, www.jubilantpharmova.com.
Source: BSE
